Skip to main content

Table 2 Putative protective probiotic strains selected. The selection aims to mimic an immune-enhancing and infection-protective probiotic community in the infant gut. These strains were subjected to subsequent network metabolic network analysis. The “Exogenous metabolite #” column shows the number of exogenous compounds required by each bacterium

From: A reverse metabolic approach to weaning: in silico identification of immune-beneficial infant gut bacteria, mining their metabolism for prebiotic feeds and sourcing these feeds in the natural product space

Putative probiotic Exogenous metabolite #
Bifidobacterium adolescentis ATCC 15703 251
Bifidobacterium angulatum DSM 20098 268
Bifidobacterium animalis subsp. lactis BB 12 248
Bifidobacterium bifidum BGN4 255
Bifidobacterium breve UCC2003 NCIMB8807 258
Bifidobacterium catenulatum DSM 16992 274
Bifidobacterium longum subsp. infantis ATCC 15697 295
Bifidobacterium longum subsp. longum CCUG 52486 289
Bifidobacterium pseudocatenulatum DSM 20438 283
Lactobacillus acidophilus NCFM 220
Lactobacillus casei subsp. casei BL23 313
Lactobacillus fermentum IFO 3956 265
Lactobacillus paracasei subsp. paracasei ATCC 25302 305
Lactobacillus plantarum WCFS1 308
Lactobacillus reuteri SD2112 ATCC 55730 261
Lactobacillus rhamnosus GG ATCC 53103 276
Akkermansia muciniphila ATCC BAA 835 208
Faecalibacterium prausnitzii M21 2 275